Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

Clinical trial NCT03919292 · SUSPENDED

Trial details

NCT number: NCT03919292
Sponsor: Virginia Commonwealth University
Status: SUSPENDED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2019-05-01
Primary completion: 2029-12-31
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.